The Latest Breaking News from JNJ

Receding inflationary pressure and the Fed’s smaller rate hike have raised investor optimism. However, amid additional rate hike fears and associated volatilities, investors could scoop up quality stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and AstraZeneca (AZN) that could help them build wealth in the market. Read on….

The stock market witnessed a decent rally in January, with cooling inflationary pressures reducing recession fears. However, the Fed’s attempts to bring inflation down to its 2% target could hurt economic growth. Hence, it could be wise to invest in shares of Johnson & Johnson (JNJ), Novartis (NVS), and LCNB…

With a recession expected this year due to the Fed’s hawkish stance, investors could look to buy fundamentally strong dividend-paying stocks Johnson & Johnson (JNJ), Kroger (KR), and Bluegreen Vacations Holding (BVH). Keep reading….

Despite cooling inflation, the Fed’s indication of continuing its hawkish stance and recession concerns could keep the stock market volatile for a while. Against this backdrop, fundamentally sound dividend stocks trading under $200, Johnson & Johnson (JNJ), Archer-Daniels-Midland (ADM), and Acuity Brands (AYI) might be solid buys for investors’ retirement…

The Fed’s intention to continue raising interest rates, disappointing economic data, and a weak earnings season could keep the stock market highly volatile. Hence, investing in quality stocks Microsoft (MSFT), Johnson (JNJ), and Novartis (NVS) could be safe. Continue reading.

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Covid vaccines took a major toll on Johnson & Johnson and Danaher early Tuesday, hitting J&J's fourth-quarter sales and Danaher's guidance.

With the Fed’s progressive interest-rate hikes keeping markets in perpetual turmoil, strong fundamentals of Johnson & Johnson (JNJ) could help investors secure decent risk-adjusted returns on their investments. Read on….

The Fed’s indication to keep raising interest rates through this year and looming recession fears will likely keep the stock market under pressure for the near term. Therefore, investors looking for stability amid an uncertain macroeconomic environment could consider buying fundamentally strong dividend-paying healthcare stocks Johnson & Johnson (JNJ), Pfizer…

With concerns of a recession weighing heavily on investors’ decisions, well-reputed companies paying stable dividends could be smart investments for investors over 50. Therefore, it might be wise for investors to buy fundamentally strong stocks like Johnson & Johnson (JNJ) and Coca-Cola (KO). Read more….

With the Fed expected to keep rates higher throughout this year, the odds of the economy tipping into a recession are rising. Amid ongoing macroeconomic uncertainties, investors may consider buying companies with reliable performance over the years for solid long-term returns. To that end, Pfizer (PFE), Johnson & Johnson (JNJ),…